Medicare Enrolled
Dr. Ahmad Abdelwahed, M.D.
Pulmonary Disease · Sylvania, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abdelwahed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abdelwahed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abdelwahed
Dr. Ahmad Abdelwahed is a pulmonary disease specialist in Sylvania, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Abdelwahed performed 783 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Abdelwahed received a total of $16,716 from 54 pharmaceutical and/or device companies across 490 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abdelwahed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 41% volume in OH
$16,716 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗783
Medicare services
Top 41% in OH for pulmonary disease
Not available
Unique patients (not deduplicated)
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
266 | $62 | $127 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
180 | $61 | $112 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
64 | $25 | $105 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
50 | $169 | $535 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
42 | $42 | $75 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
40 | $94 | $239 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $93 | $165 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
22 | $61 | $177 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $94 | $182 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $82 | $167 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
17 | $98 | $660 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
16 | $38 | $99 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $113 | $315 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,716
Total received (2018-2024)
Avg $2,388/year across 7 years
Top 12% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
490
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$859
2023
$1,115
2022
$703
2021
$1,237
2020
$1,237
2019
$1,882
2018
$9,683
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$160
Baxter Healthcare
$145
SANOFI-AVENTIS U.S. LLC
$98
Merck Sharp & Dohme LLC
$69
Amgen Inc.
$54
Takeda Pharmaceuticals U.S.A., Inc.
$49
GlaxoSmithKline, LLC.
$46
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
United Therapeutics Corporation
$39
Actelion Pharmaceuticals US, Inc.
$25
Edwards Lifesciences Corporation
$24
GENZYME CORPORATION
$20
Janssen Pharmaceuticals, Inc
$20
Bayer Healthcare Pharmaceuticals Inc.
$19
La Jolla Pharmaceutical Company
$15
Philips North America LLC
$15
PFIZER INC.
$14
Top 3 companies account for 46.9% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$5,943
Grifols USA, LLC
$2,496
AstraZeneca Pharmaceuticals LP
$1,117
GlaxoSmithKline, LLC.
$991
Boehringer Ingelheim Pharmaceuticals, Inc.
$857
Actelion Pharmaceuticals US, Inc.
$450
United Therapeutics Corporation
$439
Intuitive Surgical, Inc.
$427
Mallinckrodt Hospital Products Inc.
$344
Baxter Healthcare
$266
Merck Sharp & Dohme Corporation
$258
Astellas Pharma US Inc
$225
Mylan Specialty L.P.
$211
Insmed, Inc.
$191
Sunovion Pharmaceuticals Inc.
$181
GENZYME CORPORATION
$172
Genentech USA, Inc.
$165
Gilead Sciences, Inc.
$157
Janssen Pharmaceuticals, Inc
$149
Takeda Pharmaceuticals U.S.A., Inc.
$127
Merck Sharp & Dohme LLC
$125
SANOFI-AVENTIS U.S. LLC
$98
JAZZ PHARMACEUTICALS INC.
$90
Philips Electronics North America Corporation
$89
Jazz Pharmaceuticals Inc.
$87
Advanced Respiratory, Inc
$81
Circassia Pharmaceuticals Inc
$76
Regeneron Healthcare Solutions, Inc.
$74
Amgen Inc.
$73
CSL Behring
$68
Phadia US Inc.
$67
ADVANCED RESPIRATORY, INC
$62
La Jolla Pharmaceutical Company
$51
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$45
Harmony Biosciences LLC
$42
Shionogi Inc
$37
Electromed, Inc.
$37
Bayer Healthcare Pharmaceuticals Inc.
$35
Novartis Pharmaceuticals Corporation
$31
Shire North American Group Inc
$27
PFIZER INC.
$27
Alexion Pharmaceuticals, Inc.
$25
Edwards Lifesciences Corporation
$24
Resmed Corp
$21
Inogen, Inc.
$21
Melinta Therapeutics, Inc.
$20
Inspire Medical Systems, Inc.
$18
Paratek Pharmaceuticals, Inc.
$18
Philips North America LLC
$15
Abbott Laboratories
$14
Axsome Therapeutics, Inc.
$14
E.R. Squibb & Sons, L.L.C.
$13
Veran Medical Technologies, Inc.
$13
Mallinckrodt Enterprises LLC
$12
Top 3 companies account for 57.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ASMANEX · Adempas · Arikayce · Astral · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CRESEMBA · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · ELIQUIS · Esbriet · FASENRA · Fetroja · GIAPREZA · GLASSIA · HemoSphere · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hizentra · I-STAT · IMFINZI · INOGEN · INSPIRE · ImmunoCAP · KEYTRUDA · LONHALA MAGNAIR · MYCAMINE · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Perforomist · Prolastin-C · Prolastin-C Liquid · REMODULIN · S&RC Und · SEEBRI NEOHALER · SMARTVEST · SPIRIVA RESPIMAT · SRC Und · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · ULTOMIRIS · UPTRAVI · Utibron · WAKIX · XACDURO · XARELTO · XERAVA · XIFAXAN · XOLAIR · XYREM · Xolair · Xyrem · Yupelri · ZERBAXA · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
27
County median income
$60,095
Nearest hospital to ZIP centroid (approximate)
ASSURANCE HEALTH TOLEDO LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abdelwahed is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abdelwahed experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Abdelwahed performed 266 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Abdelwahed receive payments from pharmaceutical companies?
Yes. Dr. Abdelwahed received a total of $16,716 from 54 companies across 490 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abdelwahed's costs compare to other pulmonary diseases in Sylvania?
Dr. Abdelwahed's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abdelwahed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Sylvania
Browse pulmonary diseases in Sylvania ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in OH
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in OH
Which OH pulmonary diseases receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
Grifols USA, LLC Payments to Doctors
See all physicians who received payments from Grifols USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology